DCLK3 and acute myeloid leukemia: Moreover, MK0974 (CGRP antagonist) blocked the CLR/RAMP1 complex and promoted apoptosis in the EVI1 acute myeloid leukemia cell line, and this antagonist also attenuated p38 and ERK phosphorylation in this cell line [136].